Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents

American Journal of Human Genetics

Volumn 97, Issue 1, 2015, Pages 6-21

  Botkin, Jeffrey R ^a   Belmont, John W ^b   Berg, Jonathan S ^c   Berkman, Benjamin E ^d   Bombard, Yvonne ^e,f   Holm, Ingrid A ^g   Levy, Howard P ^h   Ormond, Kelly E ⁱ   Saal, Howard M ^j   Spinner, Nancy B ^k   Wilfond, Benjamin S ^l   McInerney, Joseph D ^m  

^a UNIVERSITY OF UTAH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^k CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^l SEATTLE CHILDREN S HOSPITAL   (United States)

^m American Society of Human Genetics   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOPTION; ARTICLE; CHILD; CHROMOSOME ANALYSIS; CLINICAL MEDICINE; CLINICAL RESEARCH; CONSANGUINITY; GENE SEQUENCE; GENE TECHNOLOGY; GENETIC SCREENING; HUMAN; NEWBORN SCREENING; PATERNITY; PHARMACOGENOMICS; PRIORITY JOURNAL; VOCATIONAL EDUCATION; ETHICS; GENETICS; GENOMICS; HETEROZYGOTE DETECTION; HISTORY; INFORMED CONSENT; LEGISLATION AND JURISPRUDENCE; MICROARRAY ANALYSIS; NEWBORN; PHARMACOGENETICS; PROCEDURES; PSYCHOLOGY; TRENDS;

ADOLESCENT; CHILD; GENETIC TESTING; GENETICS; GENOMICS; HETEROZYGOTE DETECTION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT, NEWBORN; INFORMED CONSENT BY MINORS; MICROARRAY ANALYSIS; PHARMACOGENETICS;

EID: 84937509245     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2015.05.022     Document Type: Review

References (111)

1. American Society of Human Genetics Board of Directors American College of Medical Genetics Board of Directors Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents Am. J. Hum. Genet. 57 1995 1233 1241
2. J. Lejeune, R. Turpin, and M. Gautier [Chromosomic diagnosis of mongolism] Arch. Fr. Pediatr. 16 1959 962 963
3. Y.W. Kan, M.S. Golbus, and R. Trecartin Prenatal diagnosis of sickle-cell anemia N. Engl. J. Med. 294 1976 1039 1040
4. C.H. Wade, B.S. Wilfond, and C.M. McBride Effects of genetic risk information on children's psychosocial wellbeing: a systematic review of the literature Genet. Med. 12 2010 317 326
5. B. Wilfond, and L.F. Ross From genetics to genomics: ethics, policy, and parental decision-making J. Pediatr. Psychol. 34 2009 639 647
6. R.C. Green, J.S. Berg, W.W. Grody, S.S. Kalia, B.R. Korf, C.L. Martin, A.L. McGuire, R.L. Nussbaum, J.M. O'Daniel, K.E. Ormond American College of Medical Genetics and Genomics ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing Genet. Med. 15 2013 565 574
7. Presidential Commission for the Study of Bioethical Issues (2013). Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts. December 2013. http://bioethics.gov/sites/default/files/FINALAnticipateCommunicate-PCSBI-0.pdf.
8. L.L. Berland, S.G. Silverman, R.M. Gore, W.W. Mayo-Smith, A.J. Megibow, J. Yee, J.A. Brink, M.E. Baker, M.P. Federle, W.D. Foley, and et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee J. Am. Coll. Radiol. 7 2010 754 773
9. N.M. Orme, J.G. Fletcher, H.A. Siddiki, W.S. Harmsen, M.M. O'Byrne, J.D. Port, W.J. Tremaine, H.C. Pitot, E.G. McFarland, M.E. Robinson, and et al. Incidental findings in imaging research: evaluating incidence, benefit, and burden Arch. Intern. Med. 170 2010 1525 1532
10. H.K. Tabor, B.E. Berkman, S.C. Hull, and M.J. Bamshad Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research Am. J. Med. Genet. A. 155A 2011 2916 2924
11. Y. Bombard, M. Robson, and K. Offit Revealing the incidentalome when targeting the tumor genome JAMA 310 2013 795 796
12. G.P. Jarvik, L.M. Amendola, J.S. Berg, K. Brothers, E.W. Clayton, W. Chung, B.J. Evans, J.P. Evans, S.M. Fullerton, C.J. Gallego eMERGE Act-ROR Committee and CERC Committee CSER Act-ROR Working Group Return of genomic results to research participants: the floor, the ceiling, and the choices in between Am. J. Hum. Genet. 94 2014 818 826
13. B.E. Berkman, S.C. Hull, and L. Eckstein The unintended implications of blurring the line between research and clinical care in a genomic age Per. Med. 11 2014 285 295
14. C. Gliwa, and B.E. Berkman Do researchers have an obligation to actively look for genetic incidental findings? Am. J. Bioeth. 13 2013 32 42
15. A.L. Beaudet, and J.W. Belmont Array-based DNA diagnostics: let the revolution begin Annu. Rev. Med. 59 2008 113 129
16. D.T. Miller, M.P. Adam, S. Aradhya, L.G. Biesecker, A.R. Brothman, N.P. Carter, D.M. Church, J.A. Crolla, E.E. Eichler, C.J. Epstein, and et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies Am. J. Hum. Genet. 86 2010 749 764
17. B.A. Bejjani, and L.G. Shaffer Clinical utility of contemporary molecular cytogenetics Annu. Rev. Genomics Hum. Genet. 9 2008 71 86
18. P. Borry, J.P. Fryns, P. Schotsmans, and K. Dierickx Attitudes towards carrier testing in minors: a systematic review Genet. Couns. 16 2005 341 352
19. Committee on Bioethics Committee on Genetics and American College of Medical Genetics and Genomics Social, Ethical, and Legal Issues Committee Ethical and policy issues in genetic testing and screening of children Pediatrics 131 2013 620 622
20. M. Van Riper Genetic testing and the family J. Midwifery Womens Health 50 2005 227 233
21. J.R. Sorenson, T. Jennings-Grant, and J. Newman Communication about carrier testing within hemophilia A families Am. J. Med. Genet. C. Semin. Med. Genet. 119C 2003 3 10
22. J.H. Fanos, and J.P. Johnson Perception of carrier status by cystic fibrosis siblings Am. J. Hum. Genet. 57 1995 431 438
23. R.H. Kenen, and R.M. Schmidt Stigmatization of carrier status: social implications of heterozygote genetic screening programs Am. J. Public Health 68 1978 1116 1120
24. P. Borry, J.P. Fryns, P. Schotsmans, and K. Dierickx Carrier testing in minors: a systematic review of guidelines and position papers Eur. J. Hum. Genet. 14 2006 133 138
25. K. Barlow-Stewart, L. Burnett, A. Proos, V. Howell, F. Huq, R. Lazarus, and H. Aizenberg A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students J. Med. Genet. 40 2003 e45
26. O. Järvinen, M. Hietala, A.M. Aalto, M. Arvio, A. Uutela, P. Aula, and H. Kääriäinen A retrospective study of long-term psychosocial consequences and satisfaction after carrier testing in childhood in an autosomal recessive disease: aspartylglucosaminuria Clin. Genet. 58 2000 447 454
27. O. Järvinen, A.E. Lehesjoki, M. Lindlöf, A. Uutela, and H. Kääriäinen Carrier testing of children for two X-linked diseases: A retrospective study of comprehension of the test results and social and psychological significance of the testing Pediatrics 106 2000 1460 1465
28. A. McConkie-Rosell, G.A. Spiridigliozzi, E. Melvin, D.V. Dawson, and A.M. Lachiewicz Living with genetic risk: effect on adolescent self-concept Am. J. Med. Genet. C. Semin. Med. Genet. 148C 2008 56 69
29. A. McConkie-Rosell, E.M. Heise, and G.A. Spiridigliozzi Influence of genetic risk information on parental role identity in adolescent girls and young women from families with fragile X syndrome J. Genet. Couns. 21 2012 59 71
30. R.M. Lew, A.L. Proos, L. Burnett, M. Delatycki, A. Bankier, and M.J. Fietz Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews Med. J. Aust. 197 2012 652 654
31. R.M. Lew, L. Burnett, A.L. Proos, K. Barlow-Stewart, M.B. Delatycki, A. Bankier, H. Aizenberg, M.J. Field, Y. Berman, R. Fleischer, and M. Fietz Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience J. Paediatr. Child Health 51 2015 271 279
32. L.F. Ross Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.? J. Law Med. Ethics 34 2006 753 764
33. ≥ on direct-to-consumer genetic testing in the United States Obstet. Gynecol. 110 2007 1392 1395
34. P. Borry, M.C. Cornel, and H.C. Howard Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market J. Community Genet. 1 2010 101 106
35. B. Godard, H. Kääriäinen, U. Kristoffersson, L. Tranebjaerg, D. Coviello, and S. Aymé Provision of genetic services in Europe: current practices and issues. Eur. J Hum. Genet. Suppl. 2 2003 S13 S48
36. M.L. McGowan, J.R. Fishman, R.A. Settersten Jr., M.A. Lambrix, and E.T. Juengst Gatekeepers or intermediaries? The role of clinicians in commercial genomic testing PLoS ONE 9 2014 e108484
37. H. Skirton, L. Goldsmith, L. Jackson, and A. O'Connor Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations Clin. Genet. 82 2012 210 218
38. C.S. Bloss, N.E. Wineinger, B.F. Darst, N.J. Schork, and E.J. Topol Impact of direct-to-consumer genomic testing at long term follow-up J. Med. Genet. 50 2013 393 400
39. C.S. Bloss, N.J. Schork, and E.J. Topol Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation J. Med. Genet. 51 2014 83 89
40. T. Caulfield, N.M. Ries, P.N. Ray, C. Shuman, and B. Wilson Direct-to-consumer genetic testing: good, bad or benign? Clin. Genet. 77 2010 101 105
41. U. Francke, C. Dijamco, A.K. Kiefer, N. Eriksson, B. Moiseff, J.Y. Tung, and J.L. Mountain Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing PeerJ 1 2013 e8
42. S.E. Gollust, E.S. Gordon, C. Zayac, G. Griffin, M.F. Christman, R.E. Pyeritz, L. Wawak, and B.A. Bernhardt Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants Public Health Genomics 15 2012 22 30
43. D.J. Kaufman, J.M. Bollinger, R.L. Dvoskin, and J.A. Scott Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing J. Genet. Couns. 21 2012 413 422
44. J.S. Roberts, and J. Ostergren Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical Studies Curr. Genet. Med. Rep. 1 2013 182 200
45. H.D. Nelson, M. Pappas, B. Zakher, J.P. Mitchell, L. Okinaka-Hu, and R. Fu Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation Ann. Intern. Med. 160 2014 255 266
46. K. Wasson, T.N. Sanders, N.S. Hogan, S. Cherny, and K.J. Helzlsouer Primary care patients' views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study J. Community Genet. 4 2013 495 505
47. European Society of Human Genetics Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes Eur. J. Hum. Genet. 18 2010 1271 1273
48. Gutierrez, A. (2013). Warning Letter to 23andMe. Inspections, Compliance, Enforcement, and Criminal Investigations of the U.S. Food and Drug Administration. November 22, 2014. http://www.fda.gov/iceci/enforcementactions/warningletters/2013/ucm376296.htm.
49. Knight, M. (2014) Will FDA regulations force US direct-to-consumer genetic testing companies overseas? Genetic Literacy Project, http://www.geneticliteracyproject.org/2014/05/14/will-fda-regulations-force-us-direct-to-consumer-genetic-testing-companies-overseas/.
50. P. Borry, R.E. van Hellemondt, D. Sprumont, C.F. Jales, E. Rial-Sebbag, T.M. Spranger, L. Curren, J. Kaye, H. Nys, and H. Howard Legislation on direct-to-consumer genetic testing in seven European countries Eur. J. Hum. Genet. 20 2012 715 721
51. H.C. Howard, D. Avard, and P. Borry Are the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms? Eur. J. Hum. Genet. 19 2011 1122 1126
52. A.B. Vashlishan Murray, M.J. Carson, C.A. Morris, and J. Beckwith Illusions of scientific legitimacy: misrepresented science in the direct-to-consumer genetic-testing marketplace Trends Genet. 26 2010 459 461
53. L. Goldsmith, L. Jackson, A. O'Connor, and H. Skirton Direct-to-consumer genomic testing: systematic review of the literature on user perspectives Eur. J. Hum. Genet. 20 2012 811 816
54. M. Rieder New ways to detect adverse drug reactions in pediatrics Pediatr. Clin. North Am. 59 2012 1071 1092
55. D.B. Hawcutt, B. Thompson, R.L. Smyth, and M. Pirmohamed Paediatric pharmacogenomics: an overview Arch. Dis. Child. 98 2013 232 237
56. A.K. Manickaraj, and S. Mital Personalized medicine in pediatric cardiology: do little changes make a big difference? Curr. Opin. Pediatr. 24 2012 584 591
57. J.S. Leeder, and G.L. Kearns Interpreting pharmacogenetic data in the developing neonate: the challenge of hitting a moving target Clin. Pharmacol. Ther. 92 2012 434 436
58. W.E. Evans, K.R. Crews, and C.H. Pui A health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigm Clin. Pharmacol. Ther. 94 2013 224 229
59. M.H. Cheok, and W.E. Evans Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy Nat. Rev. Cancer 6 2006 117 129
60. S.R. Rassekh, C.J. Ross, B.C. Carleton, and M.R. Hayden Cancer pharmacogenomics in children: research initiatives and progress to date Paediatr. Drugs 15 2013 71 81
61. C.A. Wall, P.E. Croarkin, C. Swintak, and B.A. Koplin Psychiatric pharmacogenomics in pediatric psychopharmacology Child Adolesc. Psychiatr. Clin. N. Am. 21 2012 773 788
62. S. Welch, M. Sharland, E.G. Lyall, G. Tudor-Williams, T. Niehues, U. Wintergerst, T. Bunupuradah, M. Hainaut, M. Della Negra, M.J. Pena PENTA Steering Committee PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection HIV Med. 10 2009 591 613
63. American Academy of Pediatrics Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs Pediatrics 106 2000 389 422
64. American College of Medical Genetics Newborn screening: toward a uniform screening panel and system Genet. Med. 8 Suppl 1 2006 1S 252S
65. A.R. Kemper, N.S. Green, N. Calonge, W.K. Lam, A.M. Comeau, A.J. Goldenberg, J. Ojodu, L.A. Prosser, S. Tanksley, and J.A. Bocchini Jr. Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children Genet. Med. 16 2014 183 187
66. T.C. Davis, S.G. Humiston, C.L. Arnold, J.A. Bocchini Jr., P.F. Bass 3rd, E.M. Kennen, A. Bocchini, P. Kyler, and M. Lloyd-Puryear Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts Pediatrics 117 2006 S326 S340
67. R.Z. Hayeems, F.A. Miller, J. Little, J.C. Carroll, J. Allanson, P. Chakraborty, B.J. Wilson, J.P. Bytautas, and R.J. Christensen Informing parents about expanded newborn screening: influences on provider involvement Pediatrics 124 2009 950 958
68. American College of Obstetricians and Gynecologists ACOG Committee Opinion No. 393, December 2007. Newborn screening Obstet. Gynecol. 110 2007 1497 1500
69. R. Faden, A.J. Chwalow, N.A. Holtzman, and S.D. Horn A survey to evaluate parental consent as public policy for neonatal screening Am. J. Public Health 72 1982 1347 1352
70. B. Liebl, U. Nennstiel-Ratzel, R. von Kries, R. Fingerhut, B. Olgemöller, A. Zapf, and A.A. Roscher Very high compliance in an expanded MS-MS-based newborn screening program despite written parental consent Prev. Med. 34 2002 127 131
71. Institute of Medicine Assessing Genetic Risks: Implications for Health and Social Policy 1994 National Academy Press
72. J.R. Botkin, E. Rothwell, R. Anderson, L. Stark, A. Goldenberg, M. Lewis, M. Burbank, and B. Wong Public attitudes regarding the use of residual newborn screening specimens for research Pediatrics 129 2012 231 238
73. F.A. Miller, R.Z. Hayeems, J.C. Carroll, B. Wilson, J. Little, J. Allanson, J.P. Bytautas, M. Paynter, R. Christensen, and P. Chaktraborty Consent for newborn screening: the attitudes of health care providers Public Health Genomics 13 2010 181 190
74. Y. Bombard, F.A. Miller, R.Z. Hayeems, J.C. Carroll, D. Avard, B.J. Wilson, J. Little, J.P. Bytautas, J. Allanson, R. Axler, and et al. Citizens' values regarding research with stored samples from newborn screening in Canada Pediatrics 129 2012 239 247
75. J.R. Botkin, E. Rothwell, R.A. Anderson, A. Goldenberg, M. Kuppermann, S.M. Dolan, N.C. Rose, and L. Stark What parents want to know about the storage and use of residual newborn bloodspots Am. J. Med. Genet. A. 164A 2014 2739 2744
76. Y. Bombard, F.A. Miller, R.Z. Hayeems, D. Avard, B.M. Knoppers, M.C. Cornel, and P. Borry The expansion of newborn screening: is reproductive benefit an appropriate pursuit? Nat. Rev. Genet. 10 2009 666 667
77. P. Borry, H. Nys, and K. Dierickx Carrier testing in minors: conflicting views Nat. Rev. Genet. 8 2007 828
78. F.A. Miller, J.S. Robert, and R.Z. Hayeems Questioning the consensus: managing carrier status results generated by newborn screening Am. J. Public Health 99 2009 210 215
79. D.B. Bailey Jr., D. Skinner, and S.F. Warren Newborn screening for developmental disabilities: reframing presumptive benefit Am. J. Public Health 95 2005 1889 1893
80. D. Alexander, and P.C. van Dyck A vision of the future of newborn screening Pediatrics 117 2006 S350 S354
81. Y. Bombard, F.A. Miller, R.Z. Hayeems, D. Avard, and B.M. Knoppers Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening Eur. J. Hum. Genet. 18 2010 751 760
82. Y. Bombard, F.A. Miller, R.Z. Hayeems, B.J. Wilson, J.C. Carroll, M. Paynter, J. Little, J. Allanson, J.P. Bytautas, and P. Chakraborty Health-care providers' views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders Eur. J. Hum. Genet. 20 2012 498 504
83. American Society of Human Genetics Social Issues Committee American College of Medical Genetics Social, Ethical, and Legal Issues Committee Genetic testing in adoption Am. J. Hum. Genet. 66 2000 761 767
84. M.D. Freundlich The case against preadoption genetic testing Child Welfare 77 1998 663 679
85. L.A. Jansen, and L.F. Ross The ethics of preadoption genetic testing Am. J. Med. Genet. 104 2001 214 220
86. V.L. Venne, J.R. Botkin, and S.S. Buys Professional opportunities and responsibilities in the provision of genetic information to children relinquished for adoption Am. J. Med. Genet. A. 119A 2003 41 46
87. C.P. Schaaf, D.A. Scott, J. Wiszniewska, and A.L. Beaudet Identification of incestuous parental relationships by SNP-based DNA microarrays Lancet 377 2011 555 556
88. C.W. Rehder, K.L. David, B. Hirsch, H.V. Toriello, C.M. Wilson, and H.M. Kearney American College of Medical Genetics and Genomics: standards and guidelines for documenting suspected consanguinity as an incidental finding of genomic testing Genet. Med. 15 2013 150 152
89. T.J. Pemberton, D. Absher, M.W. Feldman, R.M. Myers, N.A. Rosenberg, and J.Z. Li Genomic patterns of homozygosity in worldwide human populations Am. J. Hum. Genet. 91 2012 275 292
90. A.L. McGuire, M.J. Wang, and F.J. Probst Currents in contemporary bioethics. Identifying consanguinity through routine genomic analysis: reporting requirements J. Law Med. Ethics 40 2012 1040 1046
91. D.C. Wertz, J.C. Fletcher, and J.J. Mulvihill Medical geneticists confront ethical dilemmas: cross-cultural comparisons among 18 nations Am. J. Hum. Genet. 46 1990 1200 1213
92. G.M. Maruotti, G. Frisso, G. Calcagno, G. Fortunato, G. Castaldo, P. Martinelli, L. Sacchetti, and F. Salvatore Prenatal diagnosis of inherited diseases: 20 years' experience of an Italian Regional Reference Centre Clin. Chem. Lab. Med. 51 2013 2211 2217
93. S.M. Kerr, A. Campbell, L. Murphy, C. Hayward, C. Jackson, L.V. Wain, M.D. Tobin, A. Dominiczak, A. Morris, B.H. Smith, and D.J. Porteous Pedigree and genotyping quality analyses of over 10,000 DNA samples from the Generation Scotland: Scottish Family Health Study BMC Med. Genet. 14 2013 38
94. E.K. Lucast Informed consent and the misattributed paternity problem in genetic counseling Bioethics 21 2007 41 50
95. L.F. Ross Disclosing misattributed paternity Bioethics 10 1996 114 130
96. M. Palmor, and A. Fiester Incidental findings of nonparentage: a case for universal nondisclosure Pediatrics 134 2014 163 168
97. A.E. Guttmacher, M.E. Porteous, and J.D. McInerney Educating health-care professionals about genetics and genomics Nat. Rev. Genet. 8 2007 151 157
98. J.D. McInerney, E. Edelman, T. Nissen, and J.A. Scott Preparing health professionals for individualized medicine Per. Med. 9 2012 529 537
99. M.J. Dougherty, K.S. Lontok, K. Donigan, and J.D. McInerney The Crucial Challenge of Educating the Public About Genetics Curr. Genet. Med. Rep. 2 2014 48 55
100. National Coalition for Health Professional Education in Genetics (2010). Medicine's Future: Genomics for Practicing Doctors, http://www.nchpeg.org/index.php?option=com-content&view=article&id=368:developing-a-hospital-based-genomics-curriculum&catid=35:todays-highlights.
101. American Nurses Association Essential of Genetic and Genomic Nursing: Competencies, Curricula Guidelines, and Outcome Indicators Second Edition 2008 American Nurses Association
102. M. Rackover, C. Goldgar, C. Wolpert, K. Healy, J. Feiger, and J. Jenkins Establishing essential physician assistant clinical competencies guidelines for genetics and genomics J. Phys. Asst. Educ. 18 2007 47 48
103. National Human Genome Research Institute (2014). Pharmacist Competencies in Pharmacogenomics. Genetics/Genomics Competency Center, http://g-2-c-2.org/competency/pharmacist.
104. Hyland, K.M., Dasgupta, S., Garber, K., Gold, J.-A., Toriello, H., Weissbecker, K., and Waggoner, D. (2013). Medical School Core Curriculum in Genetics. Association of Professors of Human and Medical Genetics, http://media.wix.com/ugd/3a7b87-e338afb6862747c7b6c6f9183d086a7b.pdf.
105. Human Genomics Strategy Group (2012). Building on Our Inheritance: Genomic Technology in Healthcare. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/213705/dh-132382.pdf.
106. American Academy of Pediatrics (2015). Genetics in Primary Care Institute, http://www.geneticsinprimarycare.org/Pages/default.aspx.
107. National Coalition for Health Professional Education in Genetics (2007). Core Competencies in Genetics for Health Professionals (2007), http://www.nchpeg.org/index.php?option=com-content&view=article&id=237&Itemid=84.
108. American Society of Human Genetics and Jackson Laboratory (2014). Cancer Genetics Management in the Primary Care Setting, http://www.ashg.org/pdf/Cancer%20Genetics%20in%20the%20Primary%20Care%20Setting.pdf.
109. Secretary's Advisory Committee on Genetics, Health, and Society (2010). Genetics Education and Training of Health Care Professionals, Public Health Providers, and Consumers. Draft Report of the Secretary's Advisory Committee on Genetics, Health, and Society, Department of Health and Human Services. May 19, 2010. https://repository.library.georgetown.edu/bitstream/handle/10822/515612/SACGHS%20Draft%20Genetics%20Education%20and%20Training%20Report.pdf?sequence=1.
110. S.B. Haga, W. Burke, and R. Agans Primary-care physicians' access to genetic specialists: an impediment to the routine use of genomic medicine? Genet. Med. 15 2013 513 514
111. A.B. Hamilton, S. Oishi, E.M. Yano, C.E. Gammage, N.J. Marshall, and M.T. Scheuner Factors influencing organizational adoption and implementation of clinical genetic services Genet. Med. 16 2014 238 245